Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?

Ferdinand Seith; Andrea Forschner; Benjamin Weide; Brigitte Gückel; Martin Schwartz; Johannes Schwenck; Ahmed E Othman; Matthias Fenchel; Claus Garbe; Konstantin Nikolaou; Nina Schwenzer; Christian la Fougère; Christina Pfannenberg

doi:10.1136/jitc-2020-000656

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

XML

Immunotherapy biomarkers

Short report

Is there a link between very early changes of primary and secondary lymphoid organs in ¹⁸F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Seith F, Forschner A, Weide B, et al

Is there a link between very early changes of primary and secondary lymphoid organs in ¹⁸F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?

Journal for ImmunoTherapy of Cancer 2020;8:e000656. doi: 10.1136/jitc-2020-000656

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password